Henrik Hermann

Henrik Herrmann is Executive Director Technology and Business Development for DP and FG at FUJIFILM Diosynth Biotechnologies (FDB) in Denmark. He works with DP technology choices and priorities going forward as well as the overall DP business strategy for the company in terms of capabilities and capacities across manufacturing sites and scales. He has previous held roles as Director of Manufacturing Sciences and Technology (MSAT) for Drug Product and has been working in the Pharma Business for more than 20 years – starting at Novo Nordisk in 2002. Through his career his focus has been on drug product (DP) and finished goods (FG) manufacturing technologies and processes primarily at commercial scale. He joined Biogen manufacturing in 2015 in Denmark, after 3 years in China participating in bringing a new Novo Nordisk DP and FG facility into operation. In 2019 he transferred to FDB upon the company’s acquisition of the Biogen facility, and he has had the responsibility of building up the MSAT group for DP.